No analogous nucleoside triphosphate was found which acts as well as ATP in binding to and supporting catalysis of leucyltRNA synthetase from Escherichia coli MRE 600. However, there are numerous nucleotides which are able to replace ATP, but with lower efficiency. The 6-amino group of the adenine ring and the 2'-hydroxyl group of the ribose ring are essential for binding and catalytic activity. Alterations in the triphosphate moiety of the molecule can cause drastic changes in K m and/or V m a x , whereas alterations of the imidazole ring and substitutions at the 8-position of the adenine ring cause only minor losses of catalytic activity.
INTRODUCTION
Aminoacyl-tRNA synthetases catalyse the esterification of amino acids to their cognate tRNA's. They show highest specificity not only towards the amino acids and the tRNA's but also towards ATP as the source of energy for the esterification reaction. Reports that deal with their substrate recognition have presented evidence that the amino acid-activating enzymes, though utilising in vivo ATP as the common energy donor, differ considerably in their capability to recognise ATP-related structures. Among the naturally occuring nucleoside triphosphates, only 2'-dATP is able to replace ATP in some cases (1-5).
Some more detailed studies of the architecture of the ATPbinding Bites have been made with the phenylalanyl-(6), tyrosyl (7,8) and methionyl-tRNA synthetase (9,10) from Eecherichia coli. Since these studies, however, deal for the most part with nucleosidee only, we found it desirable to employ the corresponding triphosphates, in order to get further insight not only into the binding ability of various nucleotideo, but also into their catalytic efficiency. This paper describes the behaviour of several nueleoside triphosphates towards leucyl-tRNA synthetase from Escherichia coli MRE 600.
MATERIALS AND METHODS
Leucyl-tRNA synthetase was isolated simultaneously with isoleucyl-tRHA synthetase from Escherichia coli MRE 600, as will be described elsewhere (11) . The purified enzyme moved as a single band during sodium dodecyl sulfate disc gel electrophoresis and was essentially free of other tRNA-charging activities. Nueleoside phosphotransferase from carrots was purified as described previously (12) . Myokinase and pyruvate kinase were purchased from Boehringer (Mannheim, Germany). 8-Aza adenine was purchased from Fluka (Buchs, Switzerland) and converted to 8-aza adenosine according to Montgomery and Thomas (13) . 3'-Deoxy adenosine (cordycepin) was isolated (14) from the culture filtrate (15) of CordycepB militaris (strain "Lyrehaven") which was generously donated by Prof.Dr.H.Klenow and Dr.H.Loft (Copenhagen, Denmark). Arabinosyl adenine was purchased from Calbiochem (Los Angelee, California, USA), purine riboside (nebularine) and 6-mercapto purine riboside from Waldhof (Mannheim, Germany), 6-methyl amino purine riboside and 6-dimethyl amino purine riboside from Sigma (St.Louis, Missouri, USA) and tubercidin from Boehringer (Mannheim, Germany). These nucleosides were converted to their 5'-monophosphates, either enzymatically with nueleoside phosphotransf erase (12) or chemically with P0C1, (16) . The synthesis of 8-bromo adenoeine monophosphate and 8-methyl amino adenosine monophosphate followed literature instructions (17, 18) . 3'-Amino 3'-deoxy adenosine 5'-monophosphate was kindly donated by Dr.M.Morr (Braunschweig, Germany). The triphosphates of tubercidin, 8-aza adenosine, 3'-deoxy adenosine and 3'-amino 3'-deoxy adenosine were obtained from the corresponding monophosphates by action of myokinase and pyruvate kinase (19) . Arabinosyl adenine triphosphate was synthesised by the method of Chambers and Khorana (20), 8-bromo adenosine triphosphate by the method of Ikehara and Uesugi (17) , and N 1 -oxy adenosine triphosphate by the method of Cramer and Randerath (21) . The monophosphates of purine riboside, 6-methylamino purine riboside, 6-dimethylamino purine riboside, 6-mercapto purine riboside and 8-methylamino Table 1 ATP-analogues: structures and abbreviations adenosine were condensed with pyrophosphate by the method of Hoard and Ott (22) to yield the corresponding triphosphates. AMP, ADP, ATP, 2'-dATP, ITP, adenylyl (/3,7--imido)diphosphonate and adenosine 5'-0-(3-thiotriphosphate) were purchased from Boehringer (Mannheim, Germany), adenyl (a,/3-methylene )triphosphonate and adenylyl (/3,7--methylene)diphosphonate from Serva (Heidelberg, Germany). All nucleotides were purified by ion exchange chromatography. Their purity was checked by electrophoresis and by paper or thin-layer chromatography. Their concentrations were determined by the ultraviolet absorbance using absorption coefficients familiar from the literature. Table 1 gives a survey over the nucleoside triphosphates employed and the abbreviations used herein. Sodium ( P)pyrophosphate and L-( H)leucine were purchased from Amersham-Buchler (Braunschweig, Germany) and tRNA from Escherichia coli MRE 600 from Boehringer (Mannheim, Germany). The other chemicals used were of the highest purity available.
The rate of the leucyl-tRNA-formation reaction was measured under the following conditions: in a total volume of 0.15 ml containing 0.1 M Tris-HCl buffer, pH 7.5, 5 mM 2-mercapto ethanol, 10 mM magnesium chloride, 0.6 mM L-( H)leucine (with a specific activity of 100 mCi/mmole), 2.5 mg/ml tRNA, limiting amounts of leucyl-tRNA synthetase and varying concentrations of nucleotides were mixed and incubated at 37 °C. Under these conditions, the concentrations of the amino acid and tRNA were saturating, and the amount of magnesium chloride was optimal with respect to tRNA-charging. Samples of 0.02 ml were withdrawn at intervals of 2 min, and the tRNA was precipitated on filter discs (2 cm diameter) with ice-cold trichloro acetic acid. After the removal of the unbound amino acid, the activity of the precipitated tRNA was determined by scintillation counting. The initial rates of the leucyl-tRNA formation were determined from plots of the countrates vs. time. Michaelis constants and maximum velocities were evaluated from Lineweaver-Burk plots (cf. Pig. 1) and inhibition constants with regard to ATP from Dixon-plots (cf. Pig. 2 ) .
The rate of isotope-exchange was measured in a total volume of 0.25 ml containing 0.1 M Tris-HCl buffer, pH 7.5, 5 mM 2-mer- capto ethanol, 0.2 mM unlabelled L-leucine, 10 mM MgClp, 2 mM unlabelled pyrophosphate, 2 mM nucleotide and l i m i t i n g amounts of enzyme at 37 °C. The reaction was s t a r t e d by the addition of •x p a trace of ( P)pyrophosphate. At intervals of 5 min, 0.02 ml samples were taken, mixed with 0.02 ml 10$ trichloro acetic acid and centrifuged. 0.01 ml supernatant were withdrawn, pipetted onto a sheet of Whatman 3MM chromatography paper and developped by a mixture of ethyl methyl ketone : methanol : water : 0.1 M pyrophosphate : concentrated HC1 (45 : 15 s 16 : 4 : 1; v/v) as the ascending solvent (23) . The radioactivities of ATP and PP. were measured by scintillation counting. The exchange velocity was determined according to the theory of isotope-exchange at chemical equilibrium (24) .
The formation of an amino acid-ATP-enzyme complex was studied by incubating 0.2 ml of a mixture containing 0.1 M Tris-HCl, pH 7.5, 5 mM 2-mercapto ethanol, 2 mM MgCl 2 , 0.025 mM nucleotide, 0.01 mM L-(*H)leucine and 3 mg/ml leucyl-tRNA synthetase at 37 °C for 10 min. Then 0.025 ml 0.1 M EDTA were added, and the mixture was chilled in an ice bath. It was immediately run in the cold through a Sephadex G-75 column (1x16 cm). The column was developped with a solution containing 50 mM potassium phosphate buffer of pH 6.0, 50 mM potassium chloride, 2mM 2-mercapto ethanol and 1 mM EDTA; fractions of 0.5 ml were collected and the radioactivity of each fraction was determined by scintillation counting. Whenever a complex of enzyme, amino acid and nucleotide had been formed, we found typically a doublepeak elution diagram similar to that given in Pig. 3. The first Table 2 Rates of tRNA-charging, isotope-exchange and ability to form leucine-nucleotide-leucyl-tRHA synthetase complexes tested do not exhibit substrate activity but are competitive inhibitors of ATP, as was evaluated by Dixon-plots (Pig. 2 ) . The Michaelis constants K and the inhibition constants K., resp., are summarised in Table 2 .
Among the nucleotide triphosphates investigated, ATP is the best substrate for leucyl-tRNA synthetase, both with respect to binding and catalytic efficiency. It is closely followed by 3'-dATP, TuTP, fSATP, and /3/NHATP. Those may substitute for ATP reasonably well, their K is higher by roughly a factor of 2, and the velocity of tRNA-charging per equal amounts of enzyme is somewhat lower than that of ATP under saturating conditions.
Most of the other analogues belong to either of two categories. Alterations of the five-membered ring of the base constitute one category of analogues (TuTP, 8AzaATP, 8BrATP, and 8NHCH,ATP), in as much as the binding affinity is lowered, the substrate functionality remaining fairly constant. In contrast, modifications at, or near, the 6-position of the pyrimidine-ring puts the nucleotide into the other group, since the binding is generally persistent, whereas the substrate character is totally lost (PuTP to N OxyATP). The finding, in particular, that 8BrATP can support the tRNA-charging reaction, is at variance with the finding of Lawrence et al. (9) who found the analogue to be a competitive inhibitor in the case of the methionine-specific enzyme from Escherichia coli. This result cannot be due to the different methods employed, since -as will be discussed later -the nucleotide supports the PP.-exchange reaction as well. Thus it remains open, whether the discrepancy reflects differences among the ATPbinding sites of different synthetases, as suggested by several authors (6, 9) . At any rate, the better binding of an 8-substituted amino-derivative of ATP (8NHCH,ATP) in comparison to the 8-broaio analogue finds its parallel in the behaviour of the methionyl-tRNA synthetase (9) .
Another critical entity of the ATP-architecture is the ribosemoiety. Whereas the 3'-OH can be lost without any significant loss of binding energy or substrate-serving ability (3'-dATP), the presence of the 2'-OH is a prerequisite for tRNA-charging. However, it cannot be an important anchoring point for substrate binding, since the analogues 2'-dATP, araATP, and 3'A3'-dATP differ only marginally from ATP in their binding enertj.es. In contrast, phenylalanyl-tRNA synthetase accepts 2'-dATP (6), as do tyrosyl-and lysyl-tRNA synthetase and some enzymes more (25) . In the case of the methionyl-tRHA synthetase, however, 2'-dATP is only an inhibitor with poor binding ability. In our opinion, the 2'-OH serves to direct some essential groups of the ATP to their proper positions for catalysis, unless there is a yet unknown mechanism which involves an unsubstituted and sterically properly oriented hydroxyl-moiety at the 2'-position of the ribofuranoee for intermediate bonding formation in the catalytic turnover.
Loss of one or more phosphate groups, of course, destroys the substrate nature of the nucleotide. ADP and AMP are competitive inhibitors of the tRHA-charging reaction. They bind more weakly by a factor of 10 to the enzyme than ATP. Loss of the last phosphate reduces the binding constant by another order of magnitude. As mentioned already, /^NHATP supports the tRNA-charging reaction reasonably well, whereas substituting a ft,j -bridging methylene for the oxygen of ATP (/J^-CH-ATP) makes the nucleotide catalytically inactive. Here, the length and the angle of the bonds involved are apparently outside the limits that would be tolerated by the triphosphate-binding site of the enzyme (26) .
The results of the ATP-(^2P)PP i~e xchange tests confirm the findings described. It should be noted that the dependence of the substrate nature from alterations of molecular structure is even more pronounced. This effect has also been found for other synthetases (c.f. (2) and the literature cited there).
All nucleotides that are substrates for the tRNA-charging reaction are also able to form stable complexes with the enzyme and L-leucine (Table 2 ), the yield of complex being roughly proportional to the catalytic efficiency of the nucleotide in the tRNA-charging and PP.-exchange assays. After isolation, the complexes react with tRNA to form aminoaeyl-tRNA and with radioactive PI^. yielding J P-labelled nucleoBide triphosphates. In the presence of magnesium ions, the complexes are rapidly hydrolysed, while they are fairly stable for hours in magnesium-free solutions.
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